Expanding contraceptive choice increases individuals’ ability to freely choose the family planning methods that best meet their reproductive desires and needs. Join us for a two-part virtual technical consultation to identify opportunities to expand access to the levonorgestrel intrauterine system (IUS)—also known as the hormonal IUS—as part of a broader method mix.
The hormonal IUS has important advantages:
Despite these advantages, the hormonal IUS is not widely available in low- and middle-income countries. How can we overcome supply- and demand-side barriers to access?
Join the Method Choice Community of Practice, led by the Evidence to Action (E2A) Project, and the Hormonal IUS Access Group for this online event. Participants will:
Please make sure you register for BOTH DAYS!